Clinical trial Recruiting at 3 sites Interventional Ages 18 and up

Bypass versus endovascular treatment for long superficial femoral artery lesions causing claudication

Official title: Bypass Versus Endovascular Procedure in Long Lesions of the Superficial Femoral Artery in the Claudicant

Run by Assistance Publique - Hôpitaux de Paris · NCT05216731 · Data updated 2026-11-12

This trial tests whether femoro-popliteal bypass surgery or an endovascular procedure better keeps 15–25 cm superficial femoral artery blockages open in adults with moderate leg claudication.

More Femoral Neck Fractures trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment290 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations16 sites (Bordeaux and 15 other locations)
StatusRecruiting
StartedJanuary 20, 2025
Main results expectedMarch 7, 2030
Study endsMay 20, 2030
Registry record updatedOctober 3, 2025
Trial IDNCT05216731 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with unilateral Rutherford 2 or 3 lower extremity arterial disease due to a 15–25 cm TASC C or D lesion of the superficial femoral artery who are eligible for both bypass surgery and endovascular treatment are ideal candidates.

Probably not a fit

Patients with altered iliac inflow, prior surgery or stent on the affected superficial femoral artery, active bacteremia, pregnancy, breastfeeding, or contraindications to antiplatelet therapy or heparin are unlikely to be eligible or benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study directly compares surgical femoro-popliteal bypass with endovascular treatment for long (15–25 cm) lesions of the superficial femoral artery in patients with unilateral Rutherford 2–3 claudication. Eligible patients must be suitable for both procedures and have preserved or restored iliac inflow with at least one patent below-knee artery. Participants will undergo the assigned revascularization and be followed for vessel patency, symptom relief, and complications over planned follow-up visits. The aim is to generate prospective head-to-head data to inform treatment choice for long femoro-popliteal lesions.

Why it matters

Potential benefit: If successful, the trial could identify which procedure provides longer-lasting artery patency and better walking ability, helping doctors choose the best first-line treatment.

How similar studies have gone: There is no dedicated randomized head-to-head trial for these long lesions; retrospective series suggest endovascular patency may be lower than surgery but definitive prospective comparisons are lacking.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patient
* Effective contraception for the duration of research for fertile women of childbearing age
* Unilateral Rutherford 2 or 3 symptomatic Lower Extremity Artery Disease (LEAD) arteritic patient with a lesion of the superficial femoral artery Trans-Atlantic Inter-Society Consensus (TASC) C or D between 15 and 25 cm
* Patient eligible for bypass surgery and endovascular procedure
* No alteration of the upstream flow (iliac flow preserved or restored)
* Patient with at least one patent artery below the knee
* Patient informed and having signed the information and consent form to participate in the study

Exclusion Criteria:

* Known pregnancy or breastfeeding
* Iliac flow altered upstream
* History of surgery or stent on the affected superficial femoral artery
* Concomitant bacteremia (positive blood cultures in the 7 days preceding the procedure)
* Known intolerance to antiaggregants or heparin
* Contraindication to the endovascular procedure (severe renal failure contraindicating the injection of contrast product despite prior hydration, known severe allergy to iodinated contrast product \[unless the center chooses to use carbon dioxide injection\]) or bypass surgery (cardiovascular, respiratory or other comorbidities, contraindicating general anesthesia, local contraindications for bypass: skin lesion at the operative site)
* No affiliation to a social security regime or to another social protection regime
* Patient deprived of liberty or under legal protection (guardianship, trusteeship)
* Inability, according to the investigator, to understand or refusal to sign the informed consent to participate in the study (non-French speaking patient, cognitive disorders)
* Ongoing participation in another research protocol Participation in non-interventional research is authorized

Secondary exclusion criterion:

* Negative opinion from the anesthesiologist-resuscitator at the end of the pre-anesthetic consultation
* Positive pregnancy test from the pre-operative laboratory test (result received after obtaining consent, but before the surgical procedure)

Where it's running

  • Hôpital Henri Mondor, APHP
    Créteil, France
    Recruiting
  • Hôpital François Mitterrand
    Dijon, France
    Recruiting
  • CHU de Poitiers
    Poitiers, France
    Recruiting
  • CHU - Hôpitaux de Bordeaux
    Bordeaux, France
    Active not recruiting
  • Hôpital Ambroise Paré, APHP
    Boulogne-Billancourt, France
    Active not recruiting
  • Hôpital de la Cavale Blanche
    Brest, France
    Active not recruiting
Show 10 more locations
  • Centre hospitalier René Dubos
    Cergy-Pontoise, France
    Active not recruiting
  • Hôpital Edouard Herriot
    Lyon, France
    Active not recruiting
  • Hôpital de la Timone, APHP
    Marseille, France
    Not yet recruiting
  • CHU de Nice
    Nice, France
    Active not recruiting
  • CHU Carémeau
    Nîmes, France
    Not yet recruiting
  • Hôpital Européen Georges Pompidou, APHP
    Paris, France
    Active not recruiting
  • Hôpital Bichat - Claude Bernard, APHP
    Paris, France
    Active not recruiting
  • Hôpital La Pitié-Salpêtrière, APHP
    Paris, France
    Not yet recruiting
  • CHU de Rangueil
    Toulouse, France
    Active not recruiting
  • Institut Lorrain du Cœur et des Vaisseaux Louis Mathieu
    Vandœuvre-lès-Nancy, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.